Viral hepatitis: prognosis and problems
- Authors: Mikhailov M.I.1,2, Kyuregyan K.K.1,2, Malinnikova E.Y.1,2, Isaeva O.V.1,2, Karlsen A.A.1,2, Potemkin I.A.1,2, Kichatova V.S.1,2, Al-Sharabi Shukri A.S.3, Dogadov D.I.4, Korzaya L.I.4, Ignatieva M.E.5, Polyakov A.D.6
-
Affiliations:
- Russian Medical Academy of Continuous Professional Education, Ministry of Health of Russia
- I.I. Mechnikov Research Institute for Vaccines and Sera
- Peoples' Friendship University of Russia
- Research Institute of Medical Primatology
- Federal Service for Supervision of Consumer Rights Protection and Human Well-Being Directorate for the Republic of Sakha (Yakutia)
- Skolkovo Territorial Department of the Federal Service for Supervision of Consumer Rights Protection and Human Well-Being Directorate for the City of Moscow
- Issue: Vol 9, No 1 (2019)
- Pages: 71-80
- Section: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/287177
- DOI: https://doi.org/10.18565/epidem.2019.9.1.71-80
- ID: 287177
Cite item
Abstract
Full Text
![Restricted Access](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
About the authors
Mikhail I. Mikhailov
Russian Medical Academy of Continuous Professional Education, Ministry of Health of Russia; I.I. Mechnikov Research Institute for Vaccines and Sera
Email: michmich2@yandex.ru
MD; Corresponding Member of the Russian Academy of Sciences; Scientific Director, Institute of Molecular and Personalized Medicine; Department Head, Laboratory of Viral Hepatitis
Karen K. Kyuregyan
Russian Medical Academy of Continuous Professional Education, Ministry of Health of Russia; I.I. Mechnikov Research Institute for Vaccines and Sera
Email: karen-kyuregyan@yandex.ru
BD, Professor of the Russian Academy of Sciences, Head, Department for the Study of Viral Hepatitis, Research Institute of Molecular and Personalized Medicine; Leading Researcher, Laboratory of Viral Hepatitis
Elena Yu. Malinnikova
Russian Medical Academy of Continuous Professional Education, Ministry of Health of Russia; I.I. Mechnikov Research Institute for Vaccines and Sera
Email: malinacgb@mail.ru
MD, Chief External Expert in Infectious Diseases, Ministry of Health of Russia; Head, Department of Virology; Leading Researcher, Laboratory of Viral Hepatitis
Olga V. Isaeva
Russian Medical Academy of Continuous Professional Education, Ministry of Health of Russia; I.I. Mechnikov Research Institute for Vaccines and Sera
Email: isaeva.06@mail.ru
Cand. Biol. Sci., Leading Researcher, Department for the Study of Viral Hepatitis, Research Institute of Molecular and Personalized Medicine; Leading Researcher, Laboratory of Viral Hepatitis
Anastasiya A. Karlsen
Russian Medical Academy of Continuous Professional Education, Ministry of Health of Russia; I.I. Mechnikov Research Institute for Vaccines and Sera
Email: karlsen12@gmail.com
Researcher, Department for the Study of Viral Hepatitis, Research Institute of Molecular and Personalized Medicine; Researcher, Laboratory of Viral Hepatitis
Ilya A. Potemkin
Russian Medical Academy of Continuous Professional Education, Ministry of Health of Russia; I.I. Mechnikov Research Institute for Vaccines and Sera
Email: axi0ma@mail.ru
Researcher, Department for the Study of Viral Hepatitis, Research Institute of Molecular and Personalized Medicine; Researcher, Laboratory of Viral Hepatitis
Vera S. Kichatova
Russian Medical Academy of Continuous Professional Education, Ministry of Health of Russia; I.I. Mechnikov Research Institute for Vaccines and Sera
Email: vera_kichatova@mail.ru
Researcher, Department for the Study of Viral Hepatitis, Research Institute of Molecular and Personalized Medicine; Researcher, Laboratory of Viral Hepatitis
Abdurakhman Said Al-Sharabi Shukri
Peoples' Friendship University of Russia
Email: biomedical1999@mail.ru
Shukri, Postgraduate Student, Department of Microbiology
Dmitriy I. Dogadov
Research Institute of Medical Primatology
Email: dima_loko86@mail.ru
Researcher, Laboratory of Molecular Biology
Lidiya I. Korzaya
Research Institute of Medical Primatology
Email: likorzaya@rambler.ru
Head, Laboratory of Molecular Biology
Margarita E. Ignatieva
Federal Service for Supervision of Consumer Rights Protection and Human Well-Being Directorate for the Republic of Sakha (Yakutia)
Email: akutia@14.rospotrebnadzor.ru
Cand. Med. Sci., Head
Andrey D. Polyakov
Skolkovo Territorial Department of the Federal Service for Supervision of Consumer Rights Protection and Human Well-Being Directorate for the City of Moscow
Email: postoscol@mail.ru
Cand. Med. Sci., Head
References
- Lemon S.M., Ott J.J., van Damme P., Shouval D. Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention. J. Hepatol. 2017; 68 (1): 167-84.
- Foster M., Ramachandran S., Myatt K., Donovan D., Bohm S., Fiedler J. et al. Hepatitis A Virus Outbreaks Associated with Drug Use and Homelessness - California, Kentucky, Michigan and Utah, 2017. MMWR Morb Mortal Wkly Rep. 2018; 67(43): 1208-10. D0I:10.15585/mmwr.mm6743a3
- Паршли Л., Мойер М.У Новые болезни нового мира. В мире науки 2018; (7): 54- 69.
- Smith D.B., Simmonds Р., Jameel S. Consensus proposals for classification of the family Hepeviridae. J. Gen. Virol. 2014; 95: 2223-32.
- Woo P.C.Y., Lau S.K.P., Teng L.L., Cao K.Y., Wernery U., Schountz, T. et al. New Hepatitis E Virus Genotype in Bactrian Camels, Xinjiang, China, 2013. Emerg. Infect. Dis. 2016; 22(12): 2219-21.
- Teshale E.H., Hu D.J., Holmberg S.D. The two faces of hepatitis E virus. Clin. Infect. Dis. 2010; 51: 328-34.
- Михайлов М.И., Малинникова Е.Ю., Кюрегян К.К., Исаева О.В. Случай завоза вируса гепатита Е 4 генотипа в Россию. Журнал микробиологии, эпидемиологии и иммунобиологии 2016; (3): 64-9.
- Mохаммед А.М.Е., Потемкин И.А., Карлсен А.А., Исаева О.В., Кюрегян К.К., Козлов В.Г., Жаворонок С.В., Михайлов М.И. Циркуляция вируса гепатита Е кроликов на территориях с разной степенью эндемичности по гепатиту Е. Современные проблемы науки и образования 2015; (2). https://science-education.ru/ru/article/ view?id=18395
- Кожанова Т.В., Клушкина В.В., Гордейчук И.В., Кюрегян К.К., Михайлов М.И. Оценка иммунологической эффективности массовой вакцинации против гепатита В. Труды Института полиомиелита и вирусных энцефалитов имени М.П. Чумакова РАМН. Медицинская вирусология 2014; 28(1): 16-25.
- European Association for the Study of the Liver. EASL Recommendations on Treatment of Hepatitis C 2018. J. Hepatol. 2018. pii. S0168-8278(18)31968-8. doi: 10.1016/j.jhep.2018.03.026.
- Vermehren J., Susser S., Dietz.J., von Hahn T., Petersen J., Hinrichsen H. Retreatment of patients who failed DAA-combination therapies: real-world experience from a large hepatitis C resistance database. J. Hepatol. 2016; 64 (2): S188. DOI: https:// doi.org/10.1016/S0168-8278(16)00128-8.
- Wyles D.L. Resistance to DAAs: When to Look and When It Matters. Curr. HIV/AIDS Rep. 2017; 14(6): 229-37. DOI: 10.1007/ s11904-017-0369-5.
- Wyles D., Mangia A., Cheng W., Shafran S., Schwabe C., Ouyang W. Long-term persistence of HCV NS5A resistance associated substitutions after treatment with the HCV NS5A inhibitor, ledipasvir, without sofosbuvir. Antivir. Ther. 2017; 23(3):229-238. doi: 10.3851/IMP3181.
- Abravanel F., Motivier S., Chauveau M., P6ron J.-M., Izopet J. et al. Transmission of HCV NS5A Inhibitor-Resistant Variants Among HIV-Infected Men Who Have Sex With Men. Clin. Infect. Dis. 2016; 63(9): 1271-2.
- Никитин И.Г., Попович Л.Д., Потапчик Е.Г. Экономическое бремя хронического гепатита С в России. Эпидемиол. инфекц. болезни. Актуал. вопр. 2015; (6): 9-13.
- Исаева О.В., Кичатова В.С., Карлсен А.А., Солонин С.А., Дмитриев П.Н., Кюрегян К.К., Михайлов М.И. Многолетняя динамика распространения генотипов вируса гепатита С в Московском регионе. Журнал микробиологии, эпидемиологии и иммунобиологии 2016; (4): 35-42.
- Кичатова В.С., Карлсен А.А., Исаева О.В., Солонин С.А., Малинникова Е.Ю., Кюрегян К.К., Михайлов М.И. Лекарственно-резистентные варианты ВГС субитпа 1b, циркулирующие на территории Российской Федерации: анализ аминокислотных мутаций в белках NS5a и core. Журнал инфектологии 2018; 10(4): 30-6. doi: 10.22625/2072-6732-2018-10-4 30-36.
- Jacobson I.M., Asante-Appiah E., Wong P., Black T., Howe A.Y.M. Prevalence and impact of baseline NS5A resistance associated variants (RAVs) on the efficacy of elbasvir/ grazoprevir (EBR/GZR) against GT1a infection. Hepatol. Baltim. Md. 2015; 62: 1393A-4A.
- Zeuzem S., Mizokami M., Pianko S., Mangia A, Han KH, Martin R. et al. NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome. J. Hepatol. 2017; 66(5): 910-8.
- Recommendations for Testing, Managing, and Treating Hepatitis C/HCV Guidance. http://hcvguidelines.org/.
- Михайлов М.И., Ющук Н.Д., Проект программы по контролю и ликвидации вирусных гепатитов как проблемы общественного здравоохранения. Медицинская газета 2018; (11): 10-1.
- Михайлов М.И., Ющук Н.Д., Малинникова Е.Ю., Кюрегян К.К., Исаева О.В., Знойко О.О., Климова Е.А. Проект программы по контролю и ликвидации вирусных гепатитов как проблемы общественного здоровья в Российской Федерации. Инфекционные болезни: новости, мнения, обучение 2018; 7(2): 52-8.
Supplementary files
![](/img/style/loading.gif)